Thursday, May 2, 2024
HomeTagsSystemic Mastocytosis

Systemic Mastocytosis

Blueprint Medicines Reports Clinical Data Highlighting Leadership in Developing Targeted Treatment Options

Blueprint Medicines Corporation announced AYVAKIT data showing high, durable response rates and prolonged overall survival (OS) in patients with advanced systemic mastocytosis (Advanced SM),...
0FansLike
3,912FollowersFollow
0SubscribersSubscribe
spot_img

Hot Topics